Treace Medical Concepts Inc (TMCI) stock price

Treace Medical Concepts Inc (TMCI) is a Healthcare · Medical Devices company listed on NASDAQ. Price $4.53 (+0.00%), Market cap $0.18B, 52-week low–high $1.20 ~ $7.70.

Treace Medical Concepts, Inc., a medical technology company, designs, manufactures, and markets medical devices in the United States. The company offers Lapiplasty System, enables surgeons to correct all three dimensions of the bunion deformity, stabilize the first TMT joint, and allow return to weight-bearing in a walking boot; minimally invasive products for four bunion classes; Nanoplasty 3D Minimally Invasive Bunion Correction System delivers a reproducible 3D correction of the bunion deformity through a cosmetically appealing; and Percuplasty Percutaneous 3D Bunion Correction System that provides 3D correction of the bunion deformity through percutaneous incisions. It also provides Addu

Key metrics

Financial statements, price targets, institutional (13F) holdings and related news for Treace Medical Concepts Inc are updated in real time on BlackAll Trade.

Treace Medical Concepts Inc financial summary

Analyst outlook

Key ratios · profitability · growth

Frequently asked questions

What is the current Treace Medical Concepts Inc (TMCI) stock price?

Treace Medical Concepts Inc trades at $4.53 (+0.00%). Real-time quotes and charts are available on BlackAll Trade.

What is the Treace Medical Concepts Inc (TMCI) market cap?

Treace Medical Concepts Inc has a market cap of about $0.18B.

What does Treace Medical Concepts Inc (TMCI) do?

Treace Medical Concepts, Inc., a medical technology company, designs, manufactures, and markets medical devices in the United States. The company offers Lapiplasty System, enables surgeons to correct